{"transactions":[{"id":2305969,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Orthopedics"}}],"security":"Common Stock","published_at":"2022-04-05T23:52:33.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":687,"price":33.04,"value":22698.48,"ownership":{"direct":true},"balance_after":25716,"source":{"system":"sec-edgar","filing":"0001209191-22-023347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122023347/doc4.xml","form_type":"4"}},{"id":2415013,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Orthopedics"}}],"security":"Performance Share Units","published_at":"2022-02-03T21:51:17.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":9836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents performance-based vesting restricted stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the \"Product Revenue Vesting Percentage\"), as modified by a total shareholder return (\"TSR\") modifier (the \"TSR Modifier\"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25.\n\nThe Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents performance-based vesting restricted stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the \"Product Revenue Vesting Percentage\"), as modified by a total shareholder return (\"TSR\") modifier (the \"TSR Modifier\"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25.\n\nThe Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group."}],"balance_after":9836,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9836},"source":{"system":"sec-edgar","filing":"0001209191-22-006838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122006838/doc4.xml","form_type":"4"}},{"id":2415012,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Orthopedics"}}],"security":"Common Stock","published_at":"2022-02-03T21:51:17.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":9836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, February 1, 2022."}],"balance_after":26403,"source":{"system":"sec-edgar","filing":"0001209191-22-006838","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122006838/doc4.xml","form_type":"4"}},{"id":2572522,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Orthopedics"}}],"security":"Common Stock","published_at":"2021-09-13T22:02:48.000Z","date":"2021-09-11","kind":"tax_withholding","acquired":false,"shares":1045,"price":40.59,"value":42416.55,"ownership":{"direct":true},"balance_after":16567,"source":{"system":"sec-edgar","filing":"0001209191-21-055721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121055721/doc4.xml","form_type":"4"}},{"id":2759296,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Extremities"}}],"security":"Performance Share Units","published_at":"2021-04-05T22:40:17.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":6988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents market-based vesting performance stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return (\"TSR\") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES) as of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents market-based vesting performance stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return (\"TSR\") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES) as of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile."}],"balance_after":6988,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6988},"source":{"system":"sec-edgar","filing":"0001209191-21-025424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121025424/doc4.xml","form_type":"4"}},{"id":2759295,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Extremities"}}],"security":"Common Stock","published_at":"2021-04-05T22:40:17.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":6988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant\ndate, April 1, 2021."}],"balance_after":17612,"source":{"system":"sec-edgar","filing":"0001209191-21-025424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121025424/doc4.xml","form_type":"4"}},{"id":3032684,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Extremities"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-14T22:11:10.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":32945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, September 11, 2020."}],"balance_after":32945,"derivative":{"exercise_price":28.24,"expiration_date":"2030-09-11","underlying":"Common Stock","underlying_shares":32945},"source":{"system":"sec-edgar","filing":"0001209191-20-050324","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120050324/doc4.xml","form_type":"4"}},{"id":3032683,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":128361,"kind":"person","name":"Gonsalves Paul","position":1,"cik":"0001824319","reported_name":"Gonsalves Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Extremities"}}],"security":"Common Stock","published_at":"2020-09-14T22:11:10.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":10624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, September 11, 2020."}],"balance_after":10624,"source":{"system":"sec-edgar","filing":"0001209191-20-050324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120050324/doc4.xml","form_type":"4"}}]}